UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ocular allergies vs. dry eye: Helping patients relieve symptoms

Pharmacy times, 2021-03, Vol.87 (3), p.71

Marguerite, McDonald

2021

Volltextzugriff (PDF)

Biomimetic contact lenses eluting olopatadine for allergic conjunctivitis

Acta biomaterialia, 2016-09, Vol.41, p.302-311

2016

Volltextzugriff (PDF)

Rapid Onset of Action on Nasal Symptoms and Ocular Symptom Relief With Olopatadine/Mometasone Combination Nasal Spray in a Ragweed Environmental Exposure Chamber

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB69-AB69

2018

Volltextzugriff (PDF)

Severe dry eye due to isolated bilateral lacrimal gland agenesis in a child. A challenging case report and review of the literature

Indian journal of ophthalmology - case reports, 2024-01, Vol.4 (1), p.70-72

2024

Volltextzugriff (PDF)

Seasonal allergies: What every pediatrician needs to know

Contemporary pediatrics (Montvale, N.J.), 2021-03, Vol.38 (3), p.22

2021

Volltextzugriff (PDF)

Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis

Expert opinion on pharmacotherapy, 2017-07, Vol.18 (11), p.1137-1143

2017

Volltextzugriff (PDF)

The effectiveness of olopatadine hydrochloride eye drops for allergic conjunctivitis: Protocol for a systematic review

Medicine (Baltimore), 2020-02, Vol.99 (7), p.e18618

2020

Volltextzugriff (PDF)

Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine/mometasone furoate

Expert review of clinical immunology, 2023-06, Vol.19 (6), p.575-584

2023

Volltextzugriff (PDF)

Identification of potential anti‐hepatitis C virus agents targeting non structural protein 5B using computational techniques

Journal of cellular biochemistry, 2018-11, Vol.119 (10), p.8574-8587

2018

Volltextzugriff (PDF)

Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies

International journal of pharmaceutics, 2019-01, Vol.554, p.264-275

2019

Volltextzugriff (PDF)

Rapid Nasal Symptom Onset of Action and Ocular Symptom Relief With Olopatadine/Mometasone Combination Nasal Spray in Patients with Seasonal Allergic Rhinitis: A Pooled Analysis

Journal of allergy and clinical immunology, 2019-02, Vol.143 (2), p.AB62

2019

Volltextzugriff (PDF)

Olopatadine/Mometasone Combination Nasal Spray for the Treatment of Seasonal Allergic Rhinitis: A Pooled Analysis of Efficacy and Safety

Journal of allergy and clinical immunology, 2019-02, Vol.143 (2), p.AB63

2019

Volltextzugriff (PDF)

A comparative study of efficacy and tolerability of bepotastine besilate (1.5%) and olopatadine hydrochloride (0.1%) eye drops in allergic conjunctivitis in a tertiary care hospital of the southern part of India

Asian Journal of Medical Sciences, 2024-10, Vol.15 (10), p.9-14

2024

Volltextzugriff (PDF)

Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis

Clinical ophthalmology (Auckland, N.Z.), 2023-11, Vol.17, p.3477-3489

2023

Volltextzugriff (PDF)

H1-Receptor Antagonist Olopatadine Inhibits MUC5AC Secretion by Conjunctival Goblet Cells

Bulletin of experimental biology and medicine, 2021-10, Vol.171 (6), p.750-754

2021

Volltextzugriff (PDF)

Intranasal combo: fixed-dose combination of mometasone furoate and olopatadine hydrochloride in therapeutic strategies for rhinosinusitis

Otolaryngologia Polska, 2023-12, Vol.77 (6), p.43-50

2023

Volltextzugriff (PDF)

Efficacy and safety of twice-daily and once-daily olopatadine-mometasone combination nasal spray for seasonal allergic rhinitis

Annals of allergy, asthma, & immunology, 2020-02, Vol.124 (2), p.171-178.e2

2020

Volltextzugriff (PDF)

Introduction of a Recyclable Basic Ionic Solvent with Bis

Catalysis letters, 2021-10, Vol.151 (10), p.3030

2021

Volltextzugriff (PDF)

Intranasal Olopatadine-Mometasone in the Treatment of Seasonal Allergic Rhinitis

The Annals of pharmacotherapy, 2023-05, Vol.57 (5), p.570-578

2023

Volltextzugriff (PDF)

Efficacy and Safety of Olopatadine/Mometasone Combination Nasal Spray in Patients With Seasonal Allergic Rhinitis

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB173-AB173

2018

Volltextzugriff (PDF)

Rapid Onset of Action on Nasal Symptoms and Ocular Symptom Improvement With Olopatadine/Mometasone Combination Nasal Spray in Patients With Seasonal Allergic Rhinitis

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB170-AB170

2018

Volltextzugriff (PDF)

Keep Seasonal Allergy Symptoms in Check: Although Second-Generation Antihistamines Are Preferred, Patient Preference Should Drive Selection of Therapy

Pharmacy times, 2023-06, Vol.89 (6), p.56

Wick, Jeannette Y

2023

Volltextzugriff (PDF)

Pharmacists Can Provide Counseling Points for Rhinitis: Help Patients Determine Whether the Condition Is Intermittent or Recurring to Create a Treatment Plan

Pharmacy times, 2023-03, Vol.89 (3), p.52

Dillon, Jessica

2023

Volltextzugriff (PDF)

Citric Acid Suppresses the Bitter Taste of Olopatadine Hydrochloride Orally Disintegrating Tablets

Biological and Pharmaceutical Bulletin, 2017/04/01, Vol.40(4), pp.451-457

2017

Volltextzugriff (PDF)

Ophthalmic drugs: in vitro paraoxonase 1 inhibition and molecular docking studies

Biotechnology and applied biochemistry, 2022-12, Vol.69 (6), p.2273-2283

2022

Volltextzugriff (PDF)

1 – 25 von 610

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(453)
Mit Volltextzugriff
(433)

Publikationsform

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Olopatadine Hydrochloride
(408)
Science & Technology
(372)
Life Sciences & Biomedicine
(354)
Olopatadine
(284)
Humans
(245)
Male
(189)
Female
(140)
Adult
(119)
Dibenzoxepins - Therapeutic Use
(119)
Conjunctivitis, Allergic - Drug Therapy
(113)
Pharmacology & Pharmacy
(112)
Animals
(99)
Ophthalmology
(96)
Allergy
(92)
Conjunctivitis
(92)
Dibenzoxepins - Administration & Dosage
(90)
Allergic Conjunctivitis
(88)
Biological And Medical Sciences
(84)
Medical Sciences
(81)
Middle Aged
(80)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Ocular allergies vs. dry eye: Helping patients relieve symptoms

Biomimetic contact lenses eluting olopatadine for allergic conjunctivitis

Rapid Onset of Action on Nasal Symptoms and Ocular Symptom Relief With Olopatadine/Mometasone Combination Nasal Spray in a Ragweed Environmental Exposure Chamber

Severe dry eye due to isolated bilateral lacrimal gland agenesis in a child. A challenging case report and review of the literature

Seasonal allergies: What every pediatrician needs to know

Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis

The effectiveness of olopatadine hydrochloride eye drops for allergic conjunctivitis: Protocol for a systematic review

Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine/mometasone furoate

Identification of potential anti‐hepatitis C virus agents targeting non structural protein 5B using computational techniques

Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies

Rapid Nasal Symptom Onset of Action and Ocular Symptom Relief With Olopatadine/Mometasone Combination Nasal Spray in Patients with Seasonal Allergic Rhinitis: A Pooled Analysis

Olopatadine/Mometasone Combination Nasal Spray for the Treatment of Seasonal Allergic Rhinitis: A Pooled Analysis of Efficacy and Safety

A comparative study of efficacy and tolerability of bepotastine besilate (1.5%) and olopatadine hydrochloride (0.1%) eye drops in allergic conjunctivitis in a tertiary care hospital of the southern part of India

Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis

H1-Receptor Antagonist Olopatadine Inhibits MUC5AC Secretion by Conjunctival Goblet Cells

Intranasal combo: fixed-dose combination of mometasone furoate and olopatadine hydrochloride in therapeutic strategies for rhinosinusitis

Efficacy and safety of twice-daily and once-daily olopatadine-mometasone combination nasal spray for seasonal allergic rhinitis

Introduction of a Recyclable Basic Ionic Solvent with Bis

Intranasal Olopatadine-Mometasone in the Treatment of Seasonal Allergic Rhinitis

Efficacy and Safety of Olopatadine/Mometasone Combination Nasal Spray in Patients With Seasonal Allergic Rhinitis

Rapid Onset of Action on Nasal Symptoms and Ocular Symptom Improvement With Olopatadine/Mometasone Combination Nasal Spray in Patients With Seasonal Allergic Rhinitis

Keep Seasonal Allergy Symptoms in Check: Although Second-Generation Antihistamines Are Preferred, Patient Preference Should Drive Selection of Therapy

Pharmacists Can Provide Counseling Points for Rhinitis: Help Patients Determine Whether the Condition Is Intermittent or Recurring to Create a Treatment Plan

Citric Acid Suppresses the Bitter Taste of Olopatadine Hydrochloride Orally Disintegrating Tablets

Ophthalmic drugs: in vitro paraoxonase 1 inhibition and molecular docking studies

Suchergebnisse filtern